心臓弁の世界市場レポート 2025年

心臓弁市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.2％で212億6,000万米ドルに成長します。予測期間の成長は、生体工学的と組織工学的心臓弁に対する需要の増加、世界人口の高齢化、弁膜症治療の必要性、弁膜症患者の遠隔医療と遠隔患者モニタリング、手術技術の向上とロボット支援による弁膜症治療、個別化心臓弁製造のための3Dプリンティングの採用などに起因しています。予測期間の主要動向には、弁置換・修復技術の進歩、弁疾患検出と治療計画のための人工知能（ai）の統合、個別化心臓弁製造のための3Dプリンティングの採用、弁置換・修復技術の進歩、手術技術の強化とロボット支援による弁処置などがあります。

心血管疾患の有病率の増加は、心臓弁市場の成長を促進する展望です。喫煙、肥満、運動不足、その他の心血管系ストレス要因などの活動が、心血管系疾患の漸増に寄与しています。動脈に脂肪プラークが蓄積することを特徴とする冠動脈疾患は、一般的な原因です。この心臓関連の病気の急増により、心臓弁の問題に対処するための心臓弁の需要が高まっています。2023年9月現在、世界保健機関（WHO）のデータによると、非伝染性疾患（NCDs）または慢性疾患に関連する世界の死因のうち、心血管疾患が約74％とかなりの部分を占めています。

心臓弁市場の拡大は、医療支出の増加によって促進されると予想されます。医療支出は、医療商品とサービスに関連するコストを包含し、心臓弁の開発とアクセシビリティを支える重要な要因です。2022年11月、カナダ健康情報ラボは、2021年の7.6％に対し、2022年には0.8％、3,310億米ドルに上る医療支出の増加を報告しました。このような医療費の増加傾向は、心臓弁市場の成長促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の心臓弁PESTEL分析（政治、社会、技術、環境、法的、促進要因、制約要因）
• 最終用途産業の分析
• 世界の心臓弁市場成長率分析
• 世界の心臓弁市場の実績：規模と成長、2019～2024年
• 世界の心臓弁市場の予測：規模と成長、2024～2029年、2034年
• 世界の心臓弁総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の心臓弁市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 組織心臓弁
• 経カテーテル心臓弁
• 人工心臓弁
• その他
• 世界の心臓弁市場：位置別、実績と予測、2019～2024年、2024～2029年、2034年
• 大動脈弁
• 僧帽弁
• その他
• 世界の心臓弁市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 心臓弁修復
• 心臓弁置換
• 世界の心臓弁市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• 専門センター
• 心臓の研究
• その他
• 世界の心臓弁市場、組織心臓弁のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生体弁（豚、牛など）
• 同種移植弁
• 世界の心臓弁市場、経カテーテル心臓弁のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経カテーテル大動脈弁留置術（TAVI）弁
• 経カテーテル僧帽弁修復弁
• 世界の心臓弁市場、機械心臓弁のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 傾斜ディスクバルブ
• 二葉弁
• ケージボールバルブ
• 世界の心臓弁市場、その他のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 導管
• ステント弁とステントレス弁

第7章 地域別・国別分析

• 世界の心臓弁市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の心臓弁市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 心臓弁市場：競合情勢
• 心臓弁市場：企業プロファイル
  • Abbott Laboratories
  • Colibri Heart Valve LLC
  • TTK HealthCare Limited
  • Artivion Inc.
  • Edwards Lifesciences Corporation

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• Jenavalve Technology Inc.
• CryoLife Inc.
• Lepu Medical Technology Co. Ltd.
• Braile Biomedical
• Sorin Group
• Micro Interventional Devices Inc.
• Medtronic Inc.
• Lepu Medical Technology
• Edward Lifesciences Corporation
• Xeltis AG
• Meril Life Sciences Pvt. Ltd.
• Auto Tissue Berlin GmbH
• On-X Life Technologies Inc.
• Thubrikar Aortic Valve Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、戦略

• 心臓弁市場、2029年-最も新しい機会を提供する国
• 心臓弁市場、2029年-最も新しい機会を提供するセグメント
• 心臓弁市場、2029年-成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $10.89 billion in 2024 to $12.48 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $21.26 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population andThe need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3D printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3D printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

The expansion of the cardiac valves market is expected to be fueled by the increasing healthcare expenditure. Healthcare expenditure, encompassing costs associated with healthcare goods and services, is a critical factor supporting the development and accessibility of cardiac valves. In November 2022, the Canadian Institute for Health Information reported a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022, compared to 7.6% in 2021. This upward trend in healthcare spending is a significant driver of the growth observed in the cardiac valves market.

A notable trend in the cardiac valve market is the integration of technological advancements. Major players in the industry are focusing on innovative technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to enhance their market presence. These technological advancements contribute to less invasive treatment options for heart diseases, offering patients protection against life-threatening conditions such as heart stroke and cardiac arrest. In September 2022, Edwards, a leading US-based medical technology company, introduced the Sapien 3 Ultra Resilia transcatheter heart valve featuring anti-calcification technology. This technology platform was designed to irreversibly block calcium binding sites in bioprosthetic valves.

Major companies within the cardiac valves market are actively engaged in the development of innovative products, exemplified by the introduction of next-generation transcatheter aortic valve implantation (TAVI) systems to drive market revenues. Abbott, a prominent US-based medical device company, launched the Navitor TAVI system in December 2022. This self-expanding valve is designed to treat patients with symptomatic severe native aortic stenosis deemed at high or extreme risk for open-heart surgery. The Navitor TAVI system incorporates intelligent design features, including the smart PVL-sealing NaviSeal Cuff, stable and accurate placement, exceptional single-digit gradients, and uncompromised small vessel access, catering to a broad spectrum of routine to challenging anatomies.

In January 2022, Venus Medtech, a China-based company specializing in structural heart disease treatment, completed the acquisition of Cardiovalve Ltd., an Israel-based medical device company focused on developing a transfemoral mitral valve replacement system. This strategic move enables Venus Medtech to advance clinical research in Europe and the United States while accelerating clinical development and commercialization in China. The acquisition positions Venus Medtech as China's most comprehensive platform for treating mitral and tricuspid regurgitation.

Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves; Other Types
• 2) By Position: Aortic Valve; Mitral Valve; Other Positions
• 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
• 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
• Subsegments:
• 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
• 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves; Transcatheter Mitral Valve Repair Valves
• 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
• 4) By Other Types: Conduits; Stented vs. Stentless Valves
• Companies Mentioned: Abbott Laboratories; Colibri Heart Valve LLC; TTK HealthCare Limited; Artivion Inc.; Edwards Lifesciences Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Valve Market Characteristics

3. Cardiac Valve Market Trends And Strategies

4. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cardiac Valve Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cardiac Valve Market Growth Rate Analysis
• 5.4. Global Cardiac Valve Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cardiac Valve Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cardiac Valve Total Addressable Market (TAM)

6. Cardiac Valve Market Segmentation

• 6.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Heart Valves
• Transcatheter Heart Valves
• Mechanical Heart Valves
• Other Types
• 6.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aortic Valve
• Mitral Valve
• Other Positions
• 6.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Valve Repair
• Cardiac Valve Replacement
• 6.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Clinics
• Specialty Centers
• Cardiac Research Institute
• Other End Users
• 6.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioprosthetic Valves (e.g., porcine, bovine)
• Homograft Valves
• 6.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Aortic Valve Implantation (TAVI) Valves
• Transcatheter Mitral Valve Repair Valves
• 6.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tilting Disc Valves
• Bileaflet Valves
• Caged Ball Valves
• 6.8. Global Cardiac Valve Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conduits
• Stented vs. Stentless Valves

7. Cardiac Valve Market Regional And Country Analysis

• 7.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Valve Market

• 8.1. Asia-Pacific Cardiac Valve Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Valve Market

• 9.1. China Cardiac Valve Market Overview
• 9.2. China Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Valve Market

• 10.1. India Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Valve Market

• 11.1. Japan Cardiac Valve Market Overview
• 11.2. Japan Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Valve Market

• 12.1. Australia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Valve Market

• 13.1. Indonesia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Valve Market

• 14.1. South Korea Cardiac Valve Market Overview
• 14.2. South Korea Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Valve Market

• 15.1. Western Europe Cardiac Valve Market Overview
• 15.2. Western Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Valve Market

• 16.1. UK Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Valve Market

• 17.1. Germany Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Valve Market

• 18.1. France Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Valve Market

• 19.1. Italy Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Valve Market

• 20.1. Spain Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Valve Market

• 21.1. Eastern Europe Cardiac Valve Market Overview
• 21.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Valve Market

• 22.1. Russia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Valve Market

• 23.1. North America Cardiac Valve Market Overview
• 23.2. North America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Valve Market

• 24.1. USA Cardiac Valve Market Overview
• 24.2. USA Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Valve Market

• 25.1. Canada Cardiac Valve Market Overview
• 25.2. Canada Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Valve Market

• 26.1. South America Cardiac Valve Market Overview
• 26.2. South America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Valve Market

• 27.1. Brazil Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Valve Market

• 28.1. Middle East Cardiac Valve Market Overview
• 28.2. Middle East Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Valve Market

• 29.1. Africa Cardiac Valve Market Overview
• 29.2. Africa Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Valve Market Competitive Landscape And Company Profiles

• 30.1. Cardiac Valve Market Competitive Landscape
• 30.2. Cardiac Valve Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Colibri Heart Valve LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. TTK HealthCare Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Valve Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Jenavalve Technology Inc.
• 31.3. CryoLife Inc.
• 31.4. Lepu Medical Technology Co. Ltd.
• 31.5. Braile Biomedical
• 31.6. Sorin Group
• 31.7. Micro Interventional Devices Inc.
• 31.8. Medtronic Inc.
• 31.9. Lepu Medical Technology
• 31.10. Edward Lifesciences Corporation
• 31.11. Xeltis AG
• 31.12. Meril Life Sciences Pvt. Ltd.
• 31.13. Auto Tissue Berlin GmbH
• 31.14. On-X Life Technologies Inc.
• 31.15. Thubrikar Aortic Valve Inc.

32. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Valve Market

34. Recent Developments In The Cardiac Valve Market

35. Cardiac Valve Market High Potential Countries, Segments and Strategies

• 35.1 Cardiac Valve Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cardiac Valve Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cardiac Valve Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer